These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 27215895)
21. An extract of Timothy-grass pollen used as sublingual immunotherapy for summer hay fever. Kay AB Drugs Today (Barc); 2007 Dec; 43(12):841-8. PubMed ID: 18174969 [TBL] [Abstract][Full Text] [Related]
22. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract. Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262 [TBL] [Abstract][Full Text] [Related]
23. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes. Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088 [TBL] [Abstract][Full Text] [Related]
24. A Comprehensive Overview of Allergen-specific Immunotherapy Types, Recombinant and Natural Extract Allergens in the Diagnosis and Treatment of Allergies. Asoudeh Moghanloo S; Forouzanfar M; Jafarinia M; Fazlollahi MR; Kardar GA Iran J Allergy Asthma Immunol; 2022 Oct; 21(5):494-511. PubMed ID: 36341559 [TBL] [Abstract][Full Text] [Related]
25. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis. Rossi RE; Monasterolo G; Coco G; Operti D Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987 [TBL] [Abstract][Full Text] [Related]
26. Grass pollen immunotherapy: where are we now. Würtzen PA; Gupta S; Brand S; Andersen PS Immunotherapy; 2016; 8(4):399-411. PubMed ID: 26973122 [TBL] [Abstract][Full Text] [Related]
27. Recombinant allergens for pollen immunotherapy. Wallner M; Pichler U; Ferreira F Immunotherapy; 2013 Dec; 5(12):1323-38. PubMed ID: 24283843 [TBL] [Abstract][Full Text] [Related]
28. Clinical trial shows sublingual immunotherapy to be effective for treatment of children with grass pollen allergy. Wilkinson J Immunotherapy; 2012 Nov; 4(11):1091-2. PubMed ID: 23194357 [No Abstract] [Full Text] [Related]
29. A comparison of in vitro potency between European and Mexican allergen extracts and US (CBER/FDA) reference extracts. Larenas-Linnemann D; Esch RE; Guidos-Fogelbach G; Rodriguez-Pérez N Allergol Immunopathol (Madr); 2010; 38(4):170-3. PubMed ID: 20338683 [TBL] [Abstract][Full Text] [Related]
30. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis. Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092 [TBL] [Abstract][Full Text] [Related]
31. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets. Malling HJ; Lund L; Ipsen H; Poulsen L J Investig Allergol Clin Immunol; 2006; 16(3):162-8. PubMed ID: 16784009 [TBL] [Abstract][Full Text] [Related]
33. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. Burks AW; Calderon MA; Casale T; Cox L; Demoly P; Jutel M; Nelson H; Akdis CA J Allergy Clin Immunol; 2013 May; 131(5):1288-96.e3. PubMed ID: 23498595 [TBL] [Abstract][Full Text] [Related]
34. The evolution of allergy immunotherapy. Nelson HS Ann Allergy Asthma Immunol; 2021 Apr; 126(4):357-366. PubMed ID: 33271297 [TBL] [Abstract][Full Text] [Related]
35. Considerations About Pollen Used for the Production of Allergen Extracts. Codina R; Crenshaw RC; Lockey RF J Allergy Clin Immunol Pract; 2015; 3(5):676-82. PubMed ID: 26004305 [TBL] [Abstract][Full Text] [Related]
36. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. Jutel M; Agache I; Bonini S; Burks AW; Calderon M; Canonica W; Cox L; Demoly P; Frew AJ; O'Hehir R; Kleine-Tebbe J; Muraro A; Lack G; Larenas D; Levin M; Martin BL; Nelson H; Pawankar R; Pfaar O; van Ree R; Sampson H; Sublett JL; Sugita K; Du Toit G; Werfel T; Gerth van Wijk R; Zhang L; Akdis M; Akdis CA J Allergy Clin Immunol; 2016 Feb; 137(2):358-68. PubMed ID: 26853128 [TBL] [Abstract][Full Text] [Related]
37. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration. Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411 [TBL] [Abstract][Full Text] [Related]
38. Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy. Lund L; Henmar H; Würtzen PA; Lund G; Hjortskov N; Larsen JN Clin Exp Allergy; 2007 Apr; 37(4):564-71. PubMed ID: 17430354 [TBL] [Abstract][Full Text] [Related]
39. [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis]. Wolthers OD; Høst A; Frederiksen B; Halken S Ugeskr Laeger; 2012 Aug; 174(35):1989-92. PubMed ID: 22929576 [TBL] [Abstract][Full Text] [Related]
40. Antibody profiles and self-reported symptoms to pollen-related food allergens in grass pollen-allergic patients from northern Europe. Ghunaim N; Grönlund H; Kronqvist M; Grönneberg R; Söderström L; Ahlstedt S; van Hage-Hamsten M Allergy; 2005 Feb; 60(2):185-91. PubMed ID: 15647039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]